Industries › Healthcare › Pharmaceutical Preparations
Pharmaceutical Preparations
Market cap, price, and daily change for the 511 Pharmaceutical Preparations stocks we cover.
1–100 of 511
Page of 6
| LLY | Lilly (Eli) | 1099.30 | -1.17% | $1.04T |
| JNJ | Johnson & Johnson | 228.38 | -2.42% | $549.8B |
| ONC | Beone Medicines Ltd. | 270.25 | +2.83% | $390.6B |
| ABBV | AbbVie | 216.50 | -2.16% | $382.5B |
| MRK | Merck | 114.02 | -1.30% | $281.6B |
| ABT | Abbott Laboratories | 88.58 | +0.09% | $154.3B |
| PFE | Pfizer | 25.22 | -2.89% | $143.7B |
| VRTX | Vertex Pharmaceuticals | 451.60 | -1.63% | $114.6B |
| BMY | Bristol Myers Squibb | 54.00 | -2.35% | $110.3B |
| REGN | Regeneron Pharmaceuticals | 610.04 | +0.38% | $63.4B |
| ALNY | Alnylam Pharmaceuticals | 278.14 | -1.66% | $36.9B |
| TEVA | Teva Pharmaceutical Industries Ltd | 31.46 | -3.33% | $36.6B |
| ZTS | Zoetis | 78.86 | +2.09% | $33.1B |
| RPRX | Royalty Pharma Plc | 52.98 | -1.30% | $23.1B |
| UTHR | United Therapeutics Corp | 536.39 | -2.72% | $22.8B |
| ROIV | Roivant Sciences Ltd. | 31.40 | +0.67% | $22.6B |
| LGVN | Longeveron Inc. | 0.84 | -0.01% | $20.8B |
| INSM | Insmed Incorporated | 95.78 | -2.71% | $20.8B |
| VTRS | Viatris | 15.37 | -2.35% | $17.9B |
| JAZZ | Jazz Pharmaceuticals Plc | 224.57 | -1.07% | $14.1B |
| BBIO | Bridgebio Pharma, Inc. | 66.23 | -1.71% | $13.0B |
| AXSM | Axsome Therapeutics, Inc. | 250.33 | -0.62% | $12.9B |
| IONS | Ionis Pharmaceuticals Inc | 74.13 | -0.15% | $12.3B |
| ELAN | Elanco Animal Health Inc | 24.21 | +3.48% | $12.1B |
| MDGL | Madrigal Pharmaceuticals, Inc. | 505.92 | +1.23% | $11.7B |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 81.72 | +0.81% | $11.5B |
| BMRN | Biomarin Pharmaceutical Inc | 54.70 | -0.60% | $10.6B |
| CYTK | Cytokinetics Inc | 78.68 | +0.63% | $9.8B |
| NUVL | Nuvalent, Inc. | 123.41 | +0.04% | $9.7B |
| GPCR | Structure Therapeutics Inc. | 44.59 | -0.96% | $9.5B |
| CORT | Corcept Therapeutics Inc | 80.00 | -2.10% | $8.6B |
| TGTX | Tg Therapeutics, Inc. | 53.23 | +3.38% | $8.1B |
| PRAX | Praxis Precision Medicines, Inc. | 282.33 | +4.62% | $7.9B |
| SYRE | Spyre Therapeutics, Inc. | 88.27 | +0.91% | $7.7B |
| ALKS | Alkermes Plc. | 44.90 | +0.85% | $7.5B |
| PTGX | Protagonist Therapeutics, Inc | 112.59 | +0.95% | $7.2B |
| AMRN | AMARIN CORP PLCUK | 15.98 | +1.30% | $6.7B |
| RYTM | Rhythm Pharmaceuticals, Inc. | 96.81 | +0.98% | $6.6B |
| MIRM | Mirum Pharmaceuticals, Inc. | 106.92 | +4.81% | $6.5B |
| LQDA | Liquidia Corp | 71.01 | +3.43% | $6.3B |
| CNTA | Centessa Pharmaceuticals Plc | 40.06 | +0.43% | $6.2B |
| COGT | Cogent Biosciences, Inc. | 34.53 | +2.51% | $5.9B |
| LGND | Ligand Pharmaceuticals Inc | 273.81 | +3.91% | $5.5B |
| AMRX | Amneal Pharmaceuticals, Inc. | 16.20 | -0.52% | $5.2B |
| TVTX | Travere Therapeutics, Inc. | 55.07 | +1.66% | $5.1B |
| XENE | Xenon Pharmaceuticals Inc. | 52.85 | -0.58% | $5.1B |
| DNTH | Dianthus Therapeutics, Inc. /De/ | 82.47 | +0.78% | $4.5B |
| ORKA | Oruka Therapeutics, Inc. | 72.42 | +2.23% | $4.4B |
| ERAS | Erasca, Inc. | 13.68 | -2.11% | $4.3B |
| KNSA | Kiniksa Pharmaceuticals International, Plc | 55.22 | +1.84% | $4.2B |
| TNGX | Tango Therapeutics, Inc. | 27.88 | -12.60% | $4.0B |
| EWTX | Edgewise Therapeutics, Inc. | 36.77 | +5.62% | $4.0B |
| MANE | Veradermics, Inc | 93.86 | +2.24% | $3.9B |
| CPRX | Catalyst Pharmaceuticals, Inc. | 31.38 | -0.05% | $3.8B |
| CRNX | Crinetics Pharmaceuticals, Inc. | 35.90 | +0.50% | $3.8B |
| ACAD | Acadia Pharmaceuticals Inc | 21.61 | +0.02% | $3.7B |
| VKTX | Viking Therapeutics, Inc. | 30.41 | -0.08% | $3.5B |
| OGN | Organon & Co. | 13.42 | -0.07% | $3.5B |
| ARQT | Arcutis Biotherapeutics, Inc. | 26.19 | -0.11% | $3.3B |
| DYN | Dyne Therapeutics, Inc. | 19.80 | +3.18% | $3.3B |
| RCUS | Arcus Biosciences, Inc. | 24.30 | +0.73% | $3.1B |
| ALMS | Alumis Inc. | 23.37 | +1.41% | $2.9B |
| ELVN | Enliven Therapeutics, Inc. | 45.13 | +0.64% | $2.7B |
| IDYA | Ideaya Biosciences, Inc. | 31.27 | +0.03% | $2.7B |
| IRON | Disc Medicine, Inc. | 70.82 | +0.94% | $2.7B |
| RARE | Ultragenyx Pharmaceutical Inc. | 27.45 | +2.08% | $2.7B |
| SUPN | Supernus Pharmaceuticals, Inc. | 44.38 | +1.96% | $2.6B |
| KLRA | Kailera Therapeutics, Inc. | 19.57 | +2.30% | $2.5B |
| VERA | Vera Therapeutics, Inc. | 35.11 | +0.24% | $2.5B |
| TRVI | Trevi Therapeutics, Inc. | 17.20 | +5.13% | $2.4B |
| PBH | Prestige Consumer Healthcare Inc. | 46.96 | +1.89% | $2.2B |
| IMNM | Immunome Inc. | 18.73 | +1.08% | $2.1B |
| NKTR | Nektar Therapeutics | 60.99 | +0.20% | $2.1B |
| OCUL | Ocular Therapeutix, Inc | 9.41 | -2.39% | $2.1B |
| MBX | Mbx Biosciences, Inc. | 43.04 | +3.64% | $2.0B |
| BHVN | Biohaven Ltd. | 13.55 | -1.02% | $2.0B |
| MLYS | Mineralys Therapeutics, Inc. | 24.63 | -1.99% | $2.0B |
| AGIO | Agios Pharmaceuticals, Inc. | 34.16 | +3.30% | $2.0B |
| NUVB | Nuvation Bio Inc. | 5.54 | +3.94% | $1.9B |
| STOK | Stoke Therapeutics, Inc. | 30.97 | +2.43% | $1.9B |
| HRMY | Harmony Biosciences Holdings, Inc. | 33.30 | -1.32% | $1.9B |
| GENB | Generate Biomedicines, Inc. | 14.48 | +4.55% | $1.9B |
| SRPT | Sarepta Therapeutics, Inc. | 17.55 | +3.51% | $1.9B |
| NRIX | Nurix Therapeutics, Inc. | 17.53 | +2.28% | $1.8B |
| RAPP | Rapport Therapeutics, Inc. | 37.30 | +1.15% | $1.8B |
| BHC | Bausch Health Companies Inc. | 4.76 | +0.11% | $1.8B |
| AMLX | Amylyx Pharmaceuticals, Inc. | 15.65 | +2.59% | $1.7B |
| VRDN | Viridian Therapeutics, Inc.De | 16.62 | -0.48% | $1.7B |
| PGEN | Precigen, Inc. | 4.80 | +1.69% | $1.7B |
| ABCL | Abcellera Biologics Inc. | 5.54 | +1.19% | $1.7B |
| ZYME | Zymeworks Inc. | 23.13 | -0.02% | $1.7B |
| SION | Sionna Therapeutics, Inc. | 37.29 | +1.55% | $1.7B |
| SNDX | Syndax Pharmaceuticals Inc | 19.00 | -0.31% | $1.7B |
| TYRA | Tyra Biosciences, Inc. | 28.26 | -2.82% | $1.7B |
| ANAB | Anaptysbio, Inc | 57.49 | +1.34% | $1.7B |
| ANIP | Ani Pharmaceuticals Inc | 79.40 | -1.34% | $1.7B |
| INVA | Innoviva, Inc. | 22.50 | -0.73% | $1.7B |
| CAPR | Capricor Therapeutics, Inc. | 28.39 | +1.77% | $1.6B |
| SEPN | Septerna, Inc. | 36.17 | +1.17% | $1.6B |
| PVLA | Palvella Therapeutics, Inc. | 112.97 | +0.39% | $1.6B |
Page of 6
Industry classification from SEC EDGAR (SIC) · Databento EQUS.MINI (prices). Informational only — not financial advice.